Silverfin false false 31/12/2024 01/01/2024 31/12/2024 Claire Roberts 01/12/2016 Peter John Roberts 01/12/2016 29 July 2025 The principal activity of the Company during the financial year was that of specialist medical practice activities. 10506102 2024-12-31 10506102 bus:Director1 2024-12-31 10506102 bus:Director2 2024-12-31 10506102 2023-12-31 10506102 core:CurrentFinancialInstruments 2024-12-31 10506102 core:CurrentFinancialInstruments 2023-12-31 10506102 core:ShareCapital 2024-12-31 10506102 core:ShareCapital 2023-12-31 10506102 core:RetainedEarningsAccumulatedLosses 2024-12-31 10506102 core:RetainedEarningsAccumulatedLosses 2023-12-31 10506102 core:FurnitureFittings 2023-12-31 10506102 core:ToolsEquipment 2023-12-31 10506102 core:ComputerEquipment 2023-12-31 10506102 core:FurnitureFittings 2024-12-31 10506102 core:ToolsEquipment 2024-12-31 10506102 core:ComputerEquipment 2024-12-31 10506102 bus:OrdinaryShareClass1 2024-12-31 10506102 2024-01-01 2024-12-31 10506102 bus:FilletedAccounts 2024-01-01 2024-12-31 10506102 bus:SmallEntities 2024-01-01 2024-12-31 10506102 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 10506102 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 10506102 bus:Director1 2024-01-01 2024-12-31 10506102 bus:Director2 2024-01-01 2024-12-31 10506102 core:FurnitureFittings 2024-01-01 2024-12-31 10506102 core:ToolsEquipment 2024-01-01 2024-12-31 10506102 core:ComputerEquipment 2024-01-01 2024-12-31 10506102 2023-01-01 2023-12-31 10506102 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 10506102 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 10506102 (England and Wales)

ROBERTS HEALTH LTD

Unaudited Financial Statements
For the financial year ended 31 December 2024
Pages for filing with the registrar

ROBERTS HEALTH LTD

Unaudited Financial Statements

For the financial year ended 31 December 2024

Contents

ROBERTS HEALTH LTD

STATEMENT OF FINANCIAL POSITION

As at 31 December 2024
ROBERTS HEALTH LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 December 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 6,596 5,683
6,596 5,683
Current assets
Stocks 4 975 975
Debtors 5 1,568 0
Cash at bank and in hand 6 33,310 38,640
35,853 39,615
Creditors: amounts falling due within one year 7 ( 7,209) ( 7,765)
Net current assets 28,644 31,850
Total assets less current liabilities 35,240 37,533
Provision for liabilities ( 1,253) ( 1,080)
Net assets 33,987 36,453
Capital and reserves
Called-up share capital 8 100 100
Profit and loss account 33,887 36,353
Total shareholders' funds 33,987 36,453

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Roberts Health Ltd (registered number: 10506102) were approved and authorised for issue by the Board of Directors on 29 July 2025. They were signed on its behalf by:

Peter John Roberts
Director
ROBERTS HEALTH LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
ROBERTS HEALTH LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Roberts Health Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Friends Cottage, Ford, Kingsbridge, TQ7 2LN, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a reducing balance basis over its expected useful life, as follows:

Fixtures and fittings 20 % reducing balance
Tools and equipment 20 % reducing balance
Computer equipment 20 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Statement of Financial Position date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Fixtures and fittings Tools and equipment Computer equipment Total
£ £ £ £
Cost
At 01 January 2024 1,740 7,048 2,247 11,035
Additions 0 0 2,398 2,398
At 31 December 2024 1,740 7,048 4,645 13,433
Accumulated depreciation
At 01 January 2024 1,032 3,158 1,162 5,352
Charge for the financial year 142 778 565 1,485
At 31 December 2024 1,174 3,936 1,727 6,837
Net book value
At 31 December 2024 566 3,112 2,918 6,596
At 31 December 2023 708 3,890 1,085 5,683

4. Stocks

2024 2023
£ £
Stocks 975 975

There are no material differences between the replacement cost of stock and the Balance Sheet amounts.

5. Debtors

2024 2023
£ £
Trade debtors 1,568 0

6. Cash and cash equivalents

2024 2023
£ £
Cash at bank and in hand 33,310 38,640

7. Creditors: amounts falling due within one year

2024 2023
£ £
Amounts owed to directors 196 196
Accruals 2,370 2,251
Taxation and social security 4,643 5,318
7,209 7,765

8. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100 100

9. Related party transactions

Transactions with the entity's directors

2024 2023
£ £
Amounts owed to the directors 196 196

The above amounts bear no interest and there is no fixed date for repayment.